
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $52.2M | -- | -- | $0.12 | -- |
07/24/2025 | Q2 | $50.5M | -- | -- | $0.12 | -- |
04/23/2025 | Q1 | $47.8M | $47.9M | $0.12 | $0.11 | $0.01 |
01/29/2025 | Q4 | $46.2M | $46.3M | $0.12 | $0.11 | $0.02 |
10/23/2024 | Q3 | $45.8M | $45M | $0.09 | $0.08 | $0.01 |
07/24/2024 | Q2 | $47M | $44.3M | $0.07 | $0.11 | -$0.04 |
04/24/2024 | Q1 | $46.5M | $45.1M | $0.11 | $0.11 | -- |
01/24/2024 | Q4 | $39.7M | $30.2M | $0.02 | $0.06 | -$0.04 |
10/25/2023 | Q3 | -- | -- | -$1.13 | $0.03 | -$1.16 |
07/26/2023 | Q2 | -- | -- | $0.06 | $0.06 | -- |
04/26/2023 | Q1 | -- | -- | $0.11 | $0.11 | $0.01 |
01/25/2023 | Q4 | -- | -- | $0.12 | $0.13 | -$0.01 |
10/26/2022 | Q3 | -- | -- | $0.14 | $0.15 | -$0.01 |
07/27/2022 | Q2 | -- | -- | $0.16 | $0.16 | $0.01 |
04/27/2022 | Q1 | -- | -- | $0.16 | -- | -- |
01/28/2022 | Q4 | -- | -- | $0.16 | -- | -- |
10/28/2021 | Q3 | -- | -- | $0.14 | -- | -- |
07/29/2021 | Q2 | -- | -- | $0.13 | -- | -- |
05/10/2021 | Q1 | -- | -- | $0.15 | -- | -- |
01/28/2021 | Q4 | -- | -- | $0.14 | -- | -- |
10/28/2020 | Q3 | -- | -- | $0.13 | -- | -- |
07/29/2020 | Q2 | -- | -- | $0.14 | -- | -- |
04/29/2020 | Q1 | -- | -- | $0.03 | -- | -- |
01/30/2020 | Q4 | -- | -- | $0.16 | -- | -- |
10/30/2019 | Q3 | -- | -- | $0.16 | -- | -- |
07/30/2019 | Q2 | -- | -- | $0.17 | -- | -- |
04/29/2019 | Q1 | -- | -- | $0.18 | -- | -- |
01/29/2019 | Q4 | -- | -- | $0.18 | -- | -- |
10/26/2018 | Q3 | -- | -- | $0.16 | -- | -- |
07/30/2018 | Q2 | -- | -- | $0.17 | -- | -- |
04/30/2018 | Q1 | -- | -- | $0.17 | -- | -- |
01/29/2018 | Q4 | -- | -- | $0.24 | -- | -- |
10/27/2017 | Q3 | -- | -- | $0.15 | -- | -- |
07/27/2017 | Q2 | -- | -- | $0.16 | -- | -- |
04/27/2017 | Q1 | -- | -- | $0.16 | -- | -- |
01/27/2017 | Q4 | -- | -- | $0.15 | -- | -- |
10/27/2016 | Q3 | -- | -- | $0.16 | -- | -- |
07/28/2016 | Q2 | -- | -- | $0.15 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.16 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.16 | -- | -- |
10/29/2015 | Q3 | -- | -- | $0.14 | -- | -- |
Capitol Federal Financial reported $47.9M worth of top line sales in its most recent quarter.
Capitol Federal Financial announced earnings per share of $0.12 which represents a beat of analyst forecast a $0.11 per share.
Capitol Federal Financial reported -- that represents -- per share over the last quarter.
Capitol Federal Financial's earnings are forecast to grow from $0.29 per share to $0.36 per share next year representing an increase of 65.52%.
Capitol Federal Financial's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.